Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A primary or metastatic malignant neoplasm involving the thymus. This category includes malignant thymomas, thymic lymphomas, primary thymic carcinomas, and metastatic carcinomas from other anatomic sites.
Biomarker and diagnostic research for thymus cancer has been reported in the published literature.
4 clinical trials registered, 2 recruiting. Interventions under study include other interventions, procedural interventions, drug therapy, and gene therapy. Pipeline includes 1 PHASE1. Research is primarily sponsored by academic and government institutions.
55 publications have been identified in PubMed for thymus cancer. Research spans Case Report / Case Series (38%), Review / Meta-Analysis (18%), and Clinical Trial Publication (15%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 21 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 3:00 PM UTC
Research summaries | 10 | 18% |
Clinical study results | 8 | 15% |
Disease patterns and progression | 6 | 11% |
Other research | 4 | 7% |
Testing and diagnosis research | 3 | 5% |
Laboratory research | 3 | 5% |
Çalışkan Kamış Ş (2026). [PMID: 42210257](https://pubmed.ncbi.nlm.nih.gov/42210257/). *J Med Case Rep*. [Case Report / Case Series]
Dai Z (2026). [PMID: 41736142](https://pubmed.ncbi.nlm.nih.gov/41736142/). *Hered Cancer Clin Pract*. [Case Report / Case Series]
Zhou N (2026). [PMID: 42216371](https://pubmed.ncbi.nlm.nih.gov/42216371/). *Medicine (Baltimore)*. [Review / Meta-Analysis]
Ardeshir-Larinani F (2026). [PMID: 41961041](https://pubmed.ncbi.nlm.nih.gov/41961041/). *J Thorac Oncol*. [Review / Meta-Analysis]
Shirakawa M (2026). [PMID: 41924076](https://pubmed.ncbi.nlm.nih.gov/41924076/). *Ann Vasc Dis*. [Case Report / Case Series]
Schulz S (2026). [PMID: 41713788](https://pubmed.ncbi.nlm.nih.gov/41713788/). *Ann Oncol*. [Other]
Bibo L (2026). [PMID: 41823155](https://pubmed.ncbi.nlm.nih.gov/41823155/). *ANZ J Surg*. [Clinical Trial Publication]
Shintani Y (2026). [PMID: 41143979](https://pubmed.ncbi.nlm.nih.gov/41143979/). *Surg Today*. [Epidemiology / Natural History]
Tang TY (2026). [PMID: 41946119](https://pubmed.ncbi.nlm.nih.gov/41946119/). *Mol Pharmacol*. [Basic Science / Preclinical]
Xiandong W (2026). [PMID: 41727665](https://pubmed.ncbi.nlm.nih.gov/41727665/). *Front Oncol*. [Epidemiology / Natural History]